Abizer Gaslightwala insider trades

Open-market stock purchases and sales by Abizer Gaslightwala, CEO at Akari Therapeutics plc, from SEC Form 4 filings since Dec 26, 2024.

Recent trades

DateStockTradeValue
Oct 14, 2026AKTX Akari Therapeutics plcBought (not open market)$8
Oct 14, 2026AKTX Akari Therapeutics plcBought (not open market)$3
Oct 14, 2026AKTX Akari Therapeutics plcBought (not open market)$312K
Oct 14, 2026AKTX Akari Therapeutics plcBought (not open market)$125K
Sep 29, 2026AKTX Akari Therapeutics plcBought (not open market)$62.5K
Aug 18, 2026AKTX Akari Therapeutics plcBought (not open market)—
Jun 24, 2026AKTX Akari Therapeutics plcBought (not open market)—
Jun 24, 2026AKTX Akari Therapeutics plcBought (not open market)—
Dec 16, 2025AKTX Akari Therapeutics plcBought$125K
Dec 16, 2025AKTX Akari Therapeutics plcBought$312K

Companies traded

  • AKTX Akari Therapeutics plc: 9 buys, last Oct 14, 2026

Get free alerts when Abizer Gaslightwala files a new trade →